Company: ATRA
Filing Date: 2025-03-07
Form Type: 8-K
Source: 0000950170-25-035482
Chunk: 1

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-03-07
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                  
         99.1      Press Release, dated March 7, 2025                                           
 ────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                         ATARA BIOTHERAPEUTICS, INC.                                               
  Date:      March 7, 2025      By:      /s/ Eric Hyllengren                                                       
                                         Eric Hyllengren